Average Co-Inventor Count = 4.37
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glaxo Group Limited (37 from 1,168 patents)
2. Glaxo Wellcome Inc. (7 from 281 patents)
3. Glaxo S.p.a. (3 from 25 patents)
47 patents:
1. 6228853 - Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
2. 6215002 - Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
3. 6177425 - Pyrrolopyrrolone derivatives
4. 6057457 - Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
5. 5994344 - Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
6. 5646140 - 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic
7. 5641775 - 3-phenylureido-1,5-benzodiazepine-diones useful as gastrin or antagonists
8. 5637697 - 1,5-benzodiazepine derivatives and their use in medicine
9. 5585376 - 1,5-benzodiazepine derivatives having CCK and/or gastrin antagonistic
10. 5580895 - 1,5-benzodiazepine derivatives
11. 5283262 - Phenethanolamine derivatives
12. 5243076 - Phenethanolamine derivatives
13. 5225445 - Phenethanolamine derivatives having .beta..sub.2 -adrenoreceptor
14. 5221695 - Aqueous formulation containing a piperidinylcyclopentylheptenoic acid
15. 5126375 - Phenethanolamine derivatives